Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Share This Page
Email
Facebook
Twitter
August 13, 2020
Scaling a mAb Production Process to Xcellerex Bioreactors
Cytiva
This article discusses moving a monoclonal antibody (mAb) production process from a microscale bioreactor to the Xcellerex XDR single-use platform.
Learn more >>
Related Content
Video: Xcellerex XDUO 2500 Single-Use Mixer
A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
Get to know: mAb variants - eLearning
Evaluation of Fibro PrismA for Scalable Single-Use mAb Purification
Selecting Chromatography Resins for Bispecific Antibody Purification
See All Articles…